drug
MK-6194
Phase 2updated 3mo agoby $MRK Merck & Co., Inc.
Phase 2community read0 votes
indications
indications
IBD (Crohn's + UC)
all catalysts(0)
nothing on the calendar yet
Trials studying MK-6194
- phase2Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
- phase2A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
- phase1A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
- phase1Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)
- phase1A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)
- phase1MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that